Venetoclax 50 mg/100 mg is a targeted oncology medicine used in specific treatment regimens for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting the BCL-2 protein, helping susceptible cancer cells undergo programmed cell death.
Cordium Pharmaceuticals Pvt Ltd, India, supports pharmaceutical export and international supply of oncology medicines to authorized buyers, hospitals, pharmacies and pharmaceutical distributors, subject to destination-country regulations.
Product clarification: Major regulatory references list Venetoclax 50 mg and 100 mg as oral tablets, not standard injections. Buyers should verify dosage form, manufacturer, registration and documentation before ordering.
Venetoclax 50 mg/100 mg for Cancer Treatment
Venetoclax is used in specialist oncology treatment for selected patients with:
Chronic Lymphocytic Leukemia (CLL)
Acute Myeloid Leukemia (AML)
Selected CLL combination-treatment protocols
For CLL, venetoclax may be used with medicines such as obinutuzumab, rituximab or other approved targeted therapies depending on the patient's treatment plan. For certain AML patients who are unsuitable for intensive chemotherapy, it may be combined with azacitidine or decitabine.
Why Choose Venetoclax?
Key advantages of this targeted therapy include:
BCL-2 targeted mechanism
Established role in selected blood-cancer treatment
Available in 50 mg and 100 mg tablet strengths
Used in combination treatment protocols
Suitable for specialist oncology prescribing
Venetoclax is prescription-only and treatment should be initiated and supervised by an appropriately qualified healthcare professional.
Venetoclax Supply from India
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical sourcing and export support from India for eligible buyers seeking oncology medicines.
We can support inquiries from:
Hospitals and oncology centers
Pharmaceutical distributors
Pharmacies
Healthcare procurement companies
Authorized international buyers
Export Markets
USA: Venetoclax is an FDA-approved oncology medicine, including approved uses in CLL/SLL. FDA records also show generic venetoclax tablet approval in 2026.
UK: Venetoclax is used in specialist treatment of CLL and AML according to applicable UK prescribing and regulatory requirements.
UAE: Hospitals, pharmacies and authorized distributors should comply with UAE pharmaceutical import and registration requirements.
South Africa: Healthcare institutions and authorized pharmaceutical buyers should follow South African medicine procurement and import regulations.
Order Venetoclax 50 mg/100 mg
For international procurement, buyers should confirm:
Required strength
Dosage form
Quantity
Manufacturer/brand preference
Destination country
Required regulatory documents
Prescription or institutional requirements
Contact Cordium Pharmaceuticals Pvt Ltd for product availability, export documentation and quotation.
FAQs
What is Venetoclax 50 mg/100 mg used for?
It is used in specific treatment regimens for CLL and AML.
Is Venetoclax available in 50 mg and 100 mg?
Yes. Regulatory product information lists 50 mg and 100 mg venetoclax tablets.
Is Venetoclax an injection?
Major regulatory references identify these strengths as oral tablets. Any injectable product should be independently verified.
Can Venetoclax be purchased without a prescription?
No. Venetoclax is a prescription oncology medicine and requires appropriate medical supervision.
Does Cordium Pharmaceuticals export Venetoclax?
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical export and sourcing services from India, subject to product availability and destination-country regulations.
Can Venetoclax be supplied to USA, UK, UAE and South Africa?
International supply is subject to applicable import, registration, prescription and pharmaceutical regulations in each destination country.
Medical Disclaimer: This content is for educational and pharmaceutical information purposes only. Venetoclax should be used only under qualified medical supervision and according to approved prescribing information and local regulations.
Cordium Pharmaceuticals Pvt Ltd, India, supports pharmaceutical export and international supply of oncology medicines to authorized buyers, hospitals, pharmacies and pharmaceutical distributors, subject to destination-country regulations.
Product clarification: Major regulatory references list Venetoclax 50 mg and 100 mg as oral tablets, not standard injections. Buyers should verify dosage form, manufacturer, registration and documentation before ordering.
Venetoclax 50 mg/100 mg for Cancer Treatment
Venetoclax is used in specialist oncology treatment for selected patients with:
Chronic Lymphocytic Leukemia (CLL)
Acute Myeloid Leukemia (AML)
Selected CLL combination-treatment protocols
For CLL, venetoclax may be used with medicines such as obinutuzumab, rituximab or other approved targeted therapies depending on the patient's treatment plan. For certain AML patients who are unsuitable for intensive chemotherapy, it may be combined with azacitidine or decitabine.
Why Choose Venetoclax?
Key advantages of this targeted therapy include:
BCL-2 targeted mechanism
Established role in selected blood-cancer treatment
Available in 50 mg and 100 mg tablet strengths
Used in combination treatment protocols
Suitable for specialist oncology prescribing
Venetoclax is prescription-only and treatment should be initiated and supervised by an appropriately qualified healthcare professional.
Venetoclax Supply from India
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical sourcing and export support from India for eligible buyers seeking oncology medicines.
We can support inquiries from:
Hospitals and oncology centers
Pharmaceutical distributors
Pharmacies
Healthcare procurement companies
Authorized international buyers
Export Markets
USA: Venetoclax is an FDA-approved oncology medicine, including approved uses in CLL/SLL. FDA records also show generic venetoclax tablet approval in 2026.
UK: Venetoclax is used in specialist treatment of CLL and AML according to applicable UK prescribing and regulatory requirements.
UAE: Hospitals, pharmacies and authorized distributors should comply with UAE pharmaceutical import and registration requirements.
South Africa: Healthcare institutions and authorized pharmaceutical buyers should follow South African medicine procurement and import regulations.
Order Venetoclax 50 mg/100 mg
For international procurement, buyers should confirm:
Required strength
Dosage form
Quantity
Manufacturer/brand preference
Destination country
Required regulatory documents
Prescription or institutional requirements
Contact Cordium Pharmaceuticals Pvt Ltd for product availability, export documentation and quotation.
FAQs
What is Venetoclax 50 mg/100 mg used for?
It is used in specific treatment regimens for CLL and AML.
Is Venetoclax available in 50 mg and 100 mg?
Yes. Regulatory product information lists 50 mg and 100 mg venetoclax tablets.
Is Venetoclax an injection?
Major regulatory references identify these strengths as oral tablets. Any injectable product should be independently verified.
Can Venetoclax be purchased without a prescription?
No. Venetoclax is a prescription oncology medicine and requires appropriate medical supervision.
Does Cordium Pharmaceuticals export Venetoclax?
Cordium Pharmaceuticals Pvt Ltd provides international pharmaceutical export and sourcing services from India, subject to product availability and destination-country regulations.
Can Venetoclax be supplied to USA, UK, UAE and South Africa?
International supply is subject to applicable import, registration, prescription and pharmaceutical regulations in each destination country.
Medical Disclaimer: This content is for educational and pharmaceutical information purposes only. Venetoclax should be used only under qualified medical supervision and according to approved prescribing information and local regulations.
Keywords
